Published data show benefit of niraparib with AAP in HRR-deficient mCSPC

Data from the phase 3 AMPLITUDE trial (NCT04497844) have been published in Nature Medicine, showing that adding niraparib (Zejula) to abiraterone acetate (Zytiga) and prednisone (AAP) significantly improved radiographic progression-free survival…